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ABSTRACT
The Comparative Toxicogenomics Database (CTD)
is a public resource that promotes understanding
about the interaction of environmental chemicals
with gene products, and their effects on human
health. Biocurators at CTD manually curate a
triad of chemical–gene, chemical–disease and
gene–disease relationships from the literature.
These core data are then integrated to construct
chemical–gene–disease networks and to predict
many novel relationships using different types of
associated data. Since 2009, we dramatically
increased the content of CTD to 1.4 million
chemical–gene–disease data points and added
many features, statistical analyses and analytical
tools, including GeneComps and ChemComps
(to find comparable genes and chemicals that
share toxicogenomic profiles), enriched Gene
Ontology terms associated with chemicals, statis-
tically ranked chemical–disease inferences, Venn
diagram tools to discover overlapping and unique
attributes of any set of chemicals, genes or
disease, and enhanced gene pathway data
content, among other features. Together, this
wealth of expanded chemical–gene–disease data
continues to help users generate testable
hypotheses about the molecular mechanisms of
environmental diseases. CTD is freely available at
http://ctd.mdibl.org.
INTRODUCTION
The environment is believed to play an important role
in the etiology of many human diseases, and chemicals
are an important component of the environment (1).
The Comparative Toxicogenomics Database (CTD;
http://ctd.mdibl.org) is a unique resource that makes
connections between chemicals, gene products and
diseases that may not otherwise be apparent, and
provides the basis for testable hypotheses about the
mechanisms underlying the etiology of environmental
diseases (2–4).
Several valuable chemical databases currently exist (5).
CTD is distinct in three important ways: it focuses on
environmental chemicals, it manually curates and then
integrates datasets to discover novel connections, and it
functions as both a data repository as well as a tool
for generating hypotheses about chemical actions and
environmental diseases. The value and utility of CTD is
evidenced by it being indexed at numerous other data-
bases, including PubChem (6), PharmGKB (7), UniProt
(8), T3DB (9), GAD (10) and ChemID (11), and by the
inclusion of CTD’s curated information in other database
products, such as STITCH (12), ToppGene (13),
PhenoHM (14), Chem2Bio2RDF (15), UCSC Browser
(16), WhichGenes (17), ChemSpider (http://www
.chemspider.com) and RefGene (http://refgene.com). As
well, CTD datasets have been used by several independent
groups for meta-analyses to derive relationships between
environmental chemicals and complex human diseases
(18–20). Furthermore, CTD will be included as a search
option in the suite of integral databases at TOXNET,
the National Library of Medicine’s portal for toxicology
data (21).
We previously reported on CTD in an introductory
article (22); here we update the increased data content
and describe several new analytical and visualization
tools and enhancements to CTD since 2009.
NEW FEATURES
More curated data
The strength of CTD data still comes from information
being derived by professional biocurators who read and
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This process, albeit time-consuming, ensures that the
core (triad) data, which underlie the establishment of
novel relationships, are valid and accurate. Our curation
paradigm, including methods and sources of controlled
vocabularies and ontologies, and our integration strategy
used to generate inferred relationships between datasets
were described previously in detail (22). To streamline
the curation process, CTD recently designed a text-mining
application that efﬁciently prioritizes the vast toxicology
literature (23), yet information is still extracted manually
from articles. CTD curated data are then combined and
integrated with other CTD data as well as annotations
from external sources to produce a plethora of novel
inferred relationships.
In July 2010, CTD contained over 240300 molecular
interactions between 5900 unique chemicals and 17300
gene products, 11500 direct gene–disease relationships
and 8500 direct chemical–disease relationships extracted
from over 21600 publications (Table 1). Integration of
these data generates 886600 inferred gene–disease
relationships and 246600 inferred chemical–disease rela-
tionships. In total, 1.4 million chemical–gene–disease
data connections are now available for exploration and
analysis, representing a 2.5-fold increase in the content
since our original description.
New data sources and links
In addition to the increased content, CTD has also
expanded its external data sources. We now include
pathway data from Reactome (24), in addition to the pre-
viously included KEGG pathways (25). Reactome and
KEGG databases annotate genes into pathways, and
this information is then integrated with CTD genes. By
integrating these chemical–gene data with gene pathway
data, novel chemical pathway connections are generated,
allowing users to explore pathways that may be inﬂuenced
by environmental chemicals. Additionally, CTD now
includes links to gene pages at PharmGKB (7) and
chemical pages at DrugBank (26).
Enhanced data features
We have enhanced CTD data by adding three new com-
putational features.
(i) GeneComps and ChemComps. Every curated gene
and chemical now includes GeneComps and
ChemComps data tabs, respectively. These new
metrics statistically identify genes and chemicals
with shared toxicogenomic proﬁles, allowing users
to ﬁnd genes and chemicals similar to their
favorite molecule of interest as well as build
toxicogenomic networks based upon shared molecu-
lar proﬁles (27). For example, the ubiquitous
plastics component bisphenol A interacts with over
475 genes in CTD. ChemComps identiﬁes other
chemicals with similar gene interaction proﬁles and
ranks them based upon their similarity index to
produce a list of comparable chemicals that
include polychlorinated biphenyls, genistein, estra-
diol and nonylphenol (27), supporting the known
estrogenic behavior of bisphenol A.
(ii) Enriched GO terms. The gene ontology (GO) is a
well-documented and widely used annotation
system that assigns molecular function, biological
process and cellular component information to
gene products (28). Typically, GO annotations are
used to retrieve and organize extensive biological
knowledge about gene lists. Uniquely, we use GO
data to understand the actions of non-genetic mol-
ecules (chemicals) by associating GO terms to chem-
icals via their curated interacting genes. The GO
data-tab on chemical pages allows users to
explore, sort and rank the enriched GO terms to
gain a greater understanding of the biological
effects of the chemical. For example, diazinon has
over 500 enriched GO terms transferred to it via
the 215 genes that interact with this insecticide
(Figure 1). Only statistically signiﬁcant GO terms
are displayed with their calculated enrichment
score (presented as the log-transformed probability
from the hypergeometric distribution). Some of the
deeper level GO terms include annotations
describing dopamine metabolism and regulation
(not shown), providing a link between diazinon
and nerve cell processes that could help users
generate testable hypotheses about insecticide
exposure and neurological defects such as
Parkinson’s or Alzheimer’s disease. In July 2010,
CTD connected over 5000 enriched GO terms to
more than 4500 chemicals.
(iii) Inference network scores. If chemical A has
a curated interaction with gene B, and independ-
ently gene B is directly associated with disease C,
then CTD integration generates an inferred relation-
ship between chemical A and disease C (inferred via
gene B). We now utilize local network topology-
based statistics to evaluate these inferred chemical–
disease relationships (King et al. in preparation and
see Figure 2). The scores allow users to sort and
rank the predicted chemical–disease relationships
to help prioritize hypothesis testing. For example,
tetrachlorodibenzodioxin (TCDD) has an inferred
relationship with prostate cancer based on 65
commonly interacting genes (Figure 2). Notably,
this high-ranking, inferred chemical–disease
Table 1. Increase in CTD data from 2008 to 2010
Curated data July 2010 July 2008
Publications 21668 8987
Chemicals 5931 3971
Genes 17321 13300
Diseases 3818 2899
Chemical–gene interactions 240369 116067
Direct gene–disease interactions 11573 5925
Inferred gene–disease interactions 886604 349300
Direct chemical–disease interactions 8523 2569
Inferred chemical–disease interactions 246603 76970
Total chemical–gene–disease interactions 1393672 550 831
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correlating exposure to Agent Orange (which was
contaminated with TCDD) and prostate cancer
in US war veterans (29). In addition to providing
potentially valid and novel disease associations, the
genes that form the basis of chemical–disease infer-
ences in CTD may help to explain the mechanisms
underlying the etiology of a particular disease and
provide a starting point to develop testable
hypotheses about chemical effects on human health.
New tools
To help navigate the 1.4 million chemical–gene–disease
data points in CTD, we have created a suite of analytical
and visualization tools, accessible from the ‘Tools’ menu
bar.
(i) Batch Query has been previously described (22) and
still represents an efﬁcient way to download any
type of data associated with a user’s input list of
chemicals, genes or diseases.
(ii) VennViewer is a new tool that allows users to create
Venn diagrams to compare associated datasets for
chemicals, genes or diseases. A user can input any
three chemicals and determine the overlapping and
unique sets of associated data for interacting genes,
diseases, inferred KEGG and Reactome pathways,
or enriched GO terms (Figure 3a). Similar compari-
sons can be made for lists of genes or diseases. The
high-resolution images of the Venn diagram can be
downloaded.
(iii) MyGeneVenn is similar to VennViewer; however,
it allows users to compare their own gene list to
gene sets in CTD that are associated with speciﬁed
chemicals or diseases. For example, a user may have
a set of genes from a microarray experiment that
are regulated in response to bisphenol A.
MyGeneVenn can be used to determine which
genes from that set are known to interact with
resveratrol or genistein (Figure 3b) or which genes
have been previously shown to interact with bisphe-
nol A. Similarly, MyGeneVenn will let the user
resolve which genes from their set are associated
with speciﬁed diseases.
Other new features
CTD has been enhanced with many other features to
make the website even more user-friendly, including a
redesigned homepage to make navigation easier and
more intuitive, a ‘Downloads’ menu tab that allows
users to download all of CTD’s dataset ﬁles, and a
‘Help’ menu tab with links to our FAQ (which includes
step-by-step instructions on how to perform various
queries), tutorial resources (including our handy
Resource Guide for quick reference to CTD), instructions
on how to link to CTD and a site to join our email list to
stay informed about new features and releases, including
Figure 1. CTD’s unique use of enriched GO terms for chemicals. On the highlighted ‘GO’ data tab (red circle) for a chemical, users will ﬁnd
enriched GO terms. Here, the insecticide diazinon has curated interactions with 215 genes. The GO annotations for these genes are statistically
enriched and only the signiﬁcant GO terms (P-value less than 0.01, expressed as an enrichment score) are shown for the chemical (inset). Cluster and
genome frequency calculations are also provided. Users can sort the table by the column headers: Ontology, GO level, GO term, Enrichment score
and Annotated genes. All CTD pages can be downloaded by using the ‘Save to ﬁle’ feature at the bottom of every page.
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that month. Users can also request curation of speciﬁc
papers or underrepresented chemicals using the ‘Contact
us’ tab.
Lastly, we have started engaging the scientiﬁc commu-
nity in reviewing the curation at CTD. When available, the
email address of the corresponding author from a curated
paper is captured by biocurators. After each monthly
update, emails are automatically sent to the authors to
alert them that their work has been curated and to ask
them to review the data. To date, over 3900 authors have
been notiﬁed for more than 4600 papers. This interaction
with and feedback from the research community helps to
ensure the high quality of curated data, and introduces
CTD to potential new users.
SUMMARY AND FUTURE DIRECTIONS
CTD provides detailed information about manually
curated chemical–gene interactions, chemical–disease
relationships and gene–disease relationships. By
integrating these core data with other datasets, CTD
helps turn knowledge into discoveries by identifying
novel connections between chemicals, genes, diseases,
pathways and GO annotations that might not otherwise
be apparent using other biological resources.
Here we have highlighted the recent improvements
to CTD, including new data content, expanded data
sources, enhanced data features and new analytical
tools that allow users to perform meta-analyses of the
datasets. Users can also search with our query pages
that allow a multitude of parameters to be queried simul-
taneously (e.g. GO annotations, pathway terms, chemical
classes, types of interactions and diseases) to ask
sophisticated questions such as: which transcription
factors have their activity affected by heavy metals, or
how does the chemical resveratrol affect the gene p53?
Examples of how to run these queries and retrieve the
results are provided in the FAQ section of the ‘Help’
menu tab.
Figure 2. Network scores help rank chemical–disease inferences. On the highlighted ‘Disease’ data tab (red circle) for the chemical tetrachlorodi-
benzodioxin (TCDD), users ﬁnd both direct and inferred disease associations. Inferred chemical–disease relationships are enhanced with inference
network scores, allowing predicted relationships to be sorted and prioritized. In this partial screenshot, the highest inference score (408.24) associates
TCDD with prostrate cancer based upon 65 genes that interact with TCDD and independently have a direct relationship with the disease (inset
and red box). For more information about inference scores, click the ‘Help’ popup box (question mark link) in the upper-right corner of the text
section.
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of the manually curated core data in CTD, include new
inference scores for gene–disease predictions (to comple-
ment the inference scores for chemical–disease predic-
tions) and provide a new metric (‘DiseaseComps’) to
describe diseases related to each other based upon
shared toxicogenomic proﬁles. As well, we plan to
increase the utility of our inferred data for GO terms
and pathways.
All of these features continue to make CTD a unique
scientiﬁc resource that promotes understanding about the
effects of environmental chemicals on human health and
for generating testable hypotheses about the mechanisms
underlying the etiology of environmental diseases.
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